Purpose: To examine the effect of controlled heat and ultraviolet exposures
on the stability of latanoprost (Xalatan, Pharmacia & Upjohn, Kalamazoo, M
I) using highperformance liquid chromatography to derive practical recommen
dations for patients regarding its use and storage.
Methods: Using serial dilution of a latanoprost stock solution, varying con
centrations were prepared to obtain a standard curve. The accuracy and prec
ision of the high-performance liquid chromatography assay conditions were v
alidated using between-day and within-day studies. The original latanoprost
containers were stored at 4, 25, 50, and 70 degreesC, and the concentratio
n of latanoprost remaining was measured by high-performance liquid chromato
graphy at different times for up to 1 month. In addition, the original lata
noprost containers were exposed to known amounts of ultraviolet A and B rad
iation for 4 hours, and the concentration of latanoprost was measured at I-
hour intervals using high-performance liquid chromatography.
Results: The increased temperature studies showed that latanoprost remained
stable at 4 and 25 degreesC for the 30-day study duration. Analysis of con
centration versus time curves for 50 and 70 degreesC yielded a t(90) (time
for 10% degradation) of 8.25 and 1.32 days, respectively. Ultraviolet B rad
iation caused a rapid degradation of latanoprost, whereas ultraviolet A rad
iation was less effective in causing the degradation of latanoprost.
Conclusions: Latanoprost exhibits thermal and solar instability and should
ideally be stored below room temperature and in the dark. The importance of
these storage conditions should be conveyed clearly to the patient.